Quick Takeaways
- GLAZER CAPITAL, LLC filed SCHEDULE 13G for DRUGS MADE IN AMERICA ACQUISITION CORP. Ordinary Shares (DMAA).
- Disclosed ownership: 5.4%.
- Date of event: 31 Mar 2025.
GLAZER CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G Report for DRUGS MADE IN AMERICA ACQUISITION CORP. Ordinary Shares (DMAA)
- Filing Manager
- GLAZER CAPITAL, LLC
- Reporting Manager
- Glazer Capital, LLC
- Symbol
- DMAA
- Shares outstanding
- 33,510,147 shares
- Disclosed Ownership
- 1,822,952 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 16:17:57 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GLAZER CAPITAL, LLC disclosed 5.4% ownership in DRUGS MADE IN AMERICA ACQUISITION CORP. Ordinary Shares (DMAA) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 16:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 5.4% | 1,822,952 | 0 | 1,822,952 | Paul J. Glazer | Paul J. Glazer, Managing Member | |
| Paul J. Glazer | 5.4% | 1,822,952 | 0 | 1,822,952 | Paul J. Glazer | Paul J. Glazer |